Equities

Phibro Animal Health Corp

Phibro Animal Health Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)22.41
  • Today's Change0.26 / 1.17%
  • Shares traded172.94k
  • 1 Year change+79.42%
  • Beta0.5092
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform0
Hold2
Sell3
Strong Sell0

Share price forecast in USD

The 5 analysts offering 12 month price targets for Phibro Animal Health Corp have a median target of 15.00, with a high estimate of 22.00 and a low estimate of 9.00. The median estimate represents a -33.07% decrease from the last price of 22.41.
High-1.8%22.00
Med-33.1%15.00
Low-59.8%9.00

Dividends in USD

In 2024, Phibro Animal Health Corp reported a dividend of 0.48 USD, equaling last years dividend. The 4 analysts covering the company expect dividends of 0.48 USD for the upcoming fiscal year, a decrease of 1.04%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in USD

On Aug 28, 2024, Phibro Animal Health Corp reported 4th quarter 2024 earnings of 0.41 per share. This result exceeded the 0.33 consensus of the 3 analysts covering the company and exceeded last year's 4th quarter results by 7.89%.
The next earnings announcement is expected on Nov 06, 2024.
Average growth rate+24.69%
Phibro Animal Health Corp reported annual 2024 earnings of 1.19 per share on Aug 28, 2024.
Average growth rate+2.86%
More ▼

Revenue history & estimates in USD

Phibro Animal Health Corporation had 4th quarter 2024 revenues of 273.20m. This bettered the 263.25m consensus of the 2 analysts covering the company. This was 17.49% above the prior year's 4th quarter results.
Average growth rate+1.97%
Phibro Animal Health Corporation had revenues for the full year 2024 of 1.02bn. This was 4.07% above the prior year's results.
Average growth rate+6.26%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.